✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Healthium Medtech Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Healthium Medtech is 0

Growth Table
  • Healthium Medtech Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet
  • Healthium Medtech Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Healthium Medtech Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow
  • Healthium Medtech Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Healthium Medtech Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Healthium Medtech Ltd. Financials

Healthium Medtech balance sheet is weak and might have solvency issues

The debt of Healthium Medtech is decreasing.
Latest debt of Healthium Medtech is -₹145.74 Crs as of Mar-21.
This is less than Mar-20 when it was -₹18.14 Crs.

Yes, profit is increasing.
The profit of Healthium Medtech is ₹85.43 Crs for Mar 2021, ₹36.76 Crs for Mar 2020 and ₹13.9 Crs for Mar 2019

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Healthium Medtech latest dividend payout ratio is 52.21% and 3yr average dividend payout ratio is 52.21%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech